← Leaderboards
Elizabeth M. Lennon
North Carolina State University Raleigh
$921,610
Attributed
$967,391
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $126.9K · FY2014–23$200K$150K$100K$50K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$875,828 · 2
FDA$91,563 · 1
By mechanism
K01$634,327 · 1
R03$241,501 · 1
U18$91,563 · 1
Top collaborators
- Stephen Douglas Cole2 shared
Most similar at North Carolina State University Raleigh
Same institution · by research overlap
- Doodipala Samba Reddy$12,516,637
- Adam Moeser$5,105,731
- Heather R. Shive$731,308
- Brian J. Reich$2,087,452
- Jun Ninomiya-Tsuji$6,579,333
Others in their field
Top investigators on “Colitis”
- Judy H Cho · University Of Chicago$35,326,932
- Richard S Blumberg · Children'S Hospital Boston$29,664,027
- Ramnik J Xavier · Broad Institute, Inc.$26,687,621
- William A Petri · University Of Virginia$24,445,458
- Eugene B Chang · University Of Chicago$21,541,557
- Charles A Parkos · Emory University$19,966,376
Research focus
ColitisTreatment StrategyInterleukin-10MediatingProtective EffectProductionCytokineInflammatory Bowel DiseasesIntestinesMast CellMemberMediator Of Activation ProteinPlayPreventAcuteColonInflammationInflammatoryBaseIntestinal DiseasesLeadLamina PropriaAnti-InflammatoryAnti-Inflammatory Agents
Grant awards (11)
Implementation and Evaluation of Two SARS-CoV-2 Assays for Companion Animal Testing to Expand Vet-LIRN COVID-19 Capacity$40,625
U18 · FY2023 · FD
Implementation and Evaluation of Two SARS-CoV-2 Assays for Companion Animal Testing to Expand Vet-LIRN COVID-19 Capacity$50,938
U18 · FY2022 · FD
Anti-inflammatory Role of Mast Cell-Derived Bone Morphogenetic Proteins in Inflammatory Bowel Disease$120,750
R03 · FY2020 · OD · contact PI
Anti-inflammatory Role of Mast Cell-Derived Bone Morphogenetic Proteins in Inflammatory Bowel Disease$120,750
R03 · FY2019 · OD · contact PI
Anti-inflammatory Role of Mast Cell-Derived Bone Morphogenetic Proteins in Inflammatory Bowel Disease$1
R03 · FY2019 · OD · contact PI
Characterization of the Novel Protective Role of the Mast Cell in Colitis$126,899
K01 · FY2018 · OD · contact PI
Characterization of the Novel Protective Role of the Mast Cell in Colitis$1
K01 · FY2018 · OD · contact PI
Characterization of the Novel Protective Role of the Mast Cell in Colitis$126,900
K01 · FY2017 · OD · contact PI
Characterization of the Novel Protective Role of the Mast Cell in Colitis$126,900
K01 · FY2016 · OD · contact PI
Characterization of the Novel Protective Role of the Mast Cell in Colitis$126,900
K01 · FY2015 · OD · contact PI
Characterization of the Novel Protective Role of the Mast Cell in Colitis$126,727
K01 · FY2014 · OD · contact PI